Roger Crystal

Insider Reports History

Location
445 Park Ave, 10 Th Fl., New York, NY
Signature
/s/ Mark Sullivan, Attorney-in-Fact for Roger Crystal
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Roger Crystal:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Mind Medicine (MindMed) Inc. Director Stock Option (Right to Buy) 75.2K Jun 12, 2025 Direct
OPIANT PHARMACEUTICALS, INC. Chief Executive Officer, Director, 10%+ Owner Common Stock 0 $20.00 Mar 2, 2023 Direct
OPIANT PHARMACEUTICALS, INC. Chief Executive Officer, Director, 10%+ Owner Option 0 Mar 2, 2023 Direct
OPIANT PHARMACEUTICALS, INC. Chief Executive Officer, Director, 10%+ Owner Stock Option (right to buy) 0 $10.00 Mar 2, 2023 Direct

Insider Reports Filed by Roger Crystal

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MNMD Mind Medicine (MindMed) Inc. Jun 12, 2025 1 $0 4 Jun 16, 2025 Director
MNMD Mind Medicine (MindMed) Inc. Jun 10, 2024 1 $0 4 Jun 12, 2024 Director
MNMD Mind Medicine (MindMed) Inc. Jun 21, 2023 2 $0 4 Jun 23, 2023 Director
OPNT OPIANT PHARMACEUTICALS, INC. Mar 2, 2023 12 -$1.74M 4 Mar 3, 2023 Chief Executive Officer, Director, 10%+ Owner
OPNT OPIANT PHARMACEUTICALS, INC. Jan 27, 2023 1 -$27.5K 4 Jan 31, 2023 Chief Executive Officer, Director, 10%+ Owner
OPNT OPIANT PHARMACEUTICALS, INC. Jan 9, 2023 1 -$23.9K 4 Jan 9, 2023 Chief Executive Officer, Director, 10%+ Owner
OPNT OPIANT PHARMACEUTICALS, INC. Jan 5, 2023 1 -$102K 4 Jan 5, 2023 Chief Executive Officer, Director, 10%+ Owner
MNMD Mind Medicine (MindMed) Inc. Aug 11, 2022 3 $0 4 Aug 15, 2022 Director
MNMD Mind Medicine (MindMed) Inc. Aug 11, 2022 0 $0 3 Aug 15, 2022 Director
OPNT OPIANT PHARMACEUTICALS, INC. Jul 14, 2022 1 -$25K 4 Jul 15, 2022 Chief Executive Officer, Director, 10%+ Owner
OPNT OPIANT PHARMACEUTICALS, INC. Jun 27, 2022 1 $0 4 Jun 29, 2022 Chief Executive Officer, Director, 10%+ Owner
OPNT OPIANT PHARMACEUTICALS, INC. Jan 27, 2022 1 -$52.2K 4 Jan 27, 2022 Chief Executive Officer, Director, 10%+ Owner
OPNT OPIANT PHARMACEUTICALS, INC. Jan 10, 2022 1 -$32.3K 4 Jan 12, 2022 Chief Executive Officer, Director, 10%+ Owner
OPNT OPIANT PHARMACEUTICALS, INC. Jan 4, 2022 1 $0 4 Jan 5, 2022 Chief Executive Officer, Director, 10%+ Owner
OPNT OPIANT PHARMACEUTICALS, INC. Sep 16, 2021 1 $2.34K 4 Sep 16, 2021 Chief Executive Officer, Director, 10%+ Owner